Clinical Trial Update: Neurotoxicity Characterization Study of Nab-paclitaxel Versus Conventional Paclitaxel in Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing neurotoxicity of nab-paclitaxel versus conventional paclitaxel in metastatic breast cancer has completed. The study was sponsor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Nab-paclitaxel (paclitaxel protein-bound)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Fundacion Oncosur | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED